Page 10 - Epic Sciences News Today

Press release content from PR Newswire. The AP news staff was not involved in its creation.

/PRNewswire/ -- Epic Sciences, Inc. (Epic)s comprehensive liquid-biopsy platform continues to deliver compelling cancer profiling information as data...

/PRNewswire/ -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to...

/PRNewswire/ -- The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to...

/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...

/PRNewswire/ -- Epic Sciences, Inc, developer of novel diagnostics to personalize and advance the treatment and management of cancer, today announced the...

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $456.4 million for the third quarter ended September...

Cancer is not an easy target. It consists of a disease spectrum that ranges from high lethality that is spreading rapidly to locally confined malignancies without lethality over the average lifespan.

/PRNewswire/ -- The "Whole Genome And Exome Sequencing Markets" report has been added to ResearchAndMarkets.coms offering. Will all newborns receive Whole...

/PRNewswire/ -- The global circulating tumor cells market size is expected to reach USD 18.3 billion by 2027, according to a new report by Grand View Research,...